Literature DB >> 1409308

Effect of Pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study.

A Auteri1, A L Pasqui, F Bruni, M Saletti, M Di Renzo, G Bova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1409308     DOI： 10.1016/1043-6618(92)90662-u

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN： 1043-6618            Impact factor:   7.658


× No keyword cloud information.
  5 in total

1.  The detailed analysis of the changes of murine dendritic cells (DCs) induced by thymic peptide: pidotimod(PTD).

Authors:  Xiaofang Hu; Wei Zhang; Lu Wang; Nan Wan; Bing Wang; Weiwei Li; Hui Hua; Xu Hu; Fengping Shan
Journal:  Hum Vaccin Immunother       Date:  2012-08-06       Impact factor: 3.452

2.  Pidotimod: the past and the present.

Authors:  Gian Vincenzo Zuccotti; Chiara Mameli
Journal:  Ital J Pediatr       Date:  2013-12-06       Impact factor: 2.638

Review 3.  NLR-Dependent Regulation of Inflammation in Multiple Sclerosis.

Authors:  Marjan Gharagozloo; Katsiaryna V Gris; Tara Mahvelati; Abdelaziz Amrani; John R Lukens; Denis Gris
Journal:  Front Immunol       Date:  2018-01-18       Impact factor: 7.561

4.  Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia.

Authors:  Susanna Esposito; Micaela Garziano; Veronica Rainone; Daria Trabattoni; Mara Biasin; Laura Senatore; Paola Marchisio; Marta Rossi; Nicola Principi; Mario Clerici
Journal:  J Transl Med       Date:  2015-09-03       Impact factor: 5.531

5.  The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3).

Authors:  Francesca Caccuri; Antonella Bugatti; Silvia Corbellini; Sara Roversi; Alberto Zani; Pietro Mazzuca; Stefania Marsico; Arnaldo Caruso; Cinzia Giagulli
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.